Ftse Mib
33.746,66
0,00%
DAX
17.932,17
-1,10%
S&P 500
5.018,39
-0,34%
NASDAQ Composite
15.605,48
-0,33%
Bitcoin
57.316,60
-1,58%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ BioCryst Pharmaceuticals Inc (BCRX) BioCryst Pharmaceuticals Inc (BCRX) Notizie

BioCryst Pharmaceuticals Inc

BCRX
4,55
0,42 (10,17%)
02 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
22/4/202413:00GLOBEBioCryst to Report First Quarter 2024 Financial Results on..
17/4/202410:30GLOBEBioCryst Announces Approval of ORLADEYO® (berotralstat) by..
03/4/202413:00GLOBEBioCryst Reports Inducement Grants Under Nasdaq Listing Rule..
25/3/202421:01GLOBEBioCryst to Present at Upcoming Investor Conferences
05/3/202413:01GLOBEBioCryst Reports Inducement Grants Under Nasdaq Listing Rule..
04/3/202423:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202422:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202423:05EDGAR2Form S-3ASR - Automatic shelf registration statement of..
26/2/202413:05EDGAR2Form 8-K - Current report
26/2/202413:00GLOBEBioCryst Reports Fourth Quarter and Full Year 2023 Financial..
26/2/202411:57IHMARKETNEWSU.S. Index Futures Dip Amid Inflation Data Anticipation, Oil..
23/2/202413:00GLOBEBioCryst Presents New Real-world Data Showing Rapid,..
21/2/202422:01GLOBEBioCryst to Present at Upcoming Investor Conferences
19/2/202413:54GLOBEBioCryst Launches ORLADEYO® (berotralstat) in Italy
14/2/202422:21EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202415:02EDGAR2Form SC 13G - Statement of acquisition of beneficial..
12/2/202413:00GLOBEBioCryst to Report Fourth Quarter 2023 Financial Results on..
05/2/202413:00GLOBEBioCryst to Present New ORLADEYO® (berotralstat) Real-world..
02/2/202413:00GLOBEBioCryst Reports Inducement Grants Under Nasdaq Listing Rule..
24/1/202423:23EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
18/1/202423:21EDGAR2Form 8-K - Current report
08/1/202413:02EDGAR2Form 8-K - Current report
05/1/202422:01GLOBEBioCryst Announces Preliminary Full Year 2023 ORLADEYO®..
04/1/202422:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202422:01GLOBEBioCryst Reports Inducement Grants Under Nasdaq Listing Rule..
03/1/202413:00GLOBEBioCryst to Present at 42nd Annual J.P. Morgan Healthcare..
20/12/202322:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202322:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202322:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202322:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202322:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202313:00GLOBEBioCryst Announces Publication of Data from Open-label..
18/12/202322:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202322:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202322:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202322:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202322:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202322:01GLOBEBioCryst Reports Inducement Grants Under Nasdaq Listing Rule..
01/12/202322:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202322:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202313:37EDGAR2Form 8-K - Current report
30/11/202315:04EDGAR2Form 8-K - Current report
29/11/202313:00GLOBEBioCryst Announces Approval of ORLADEYO® (berotralstat) by..
21/11/202322:01GLOBEBioCryst to Present at Upcoming Investor Conferences
21/11/202313:00GLOBEBioCryst Launches ORLADEYO® (berotralstat) in Spain
10/11/202313:00GLOBEBioCryst Presents New Real-world Data Showing Reduced Attack..
08/11/202322:29EDGAR2Form S-8 - Securities to be offered to employees in employee..
08/11/202322:12EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202322:01GLOBEBioCryst Reports Inducement Grants Under Nasdaq Listing Rule..
03/11/202317:16EDGAR2Form 8-K - Current report
Apertura: 4,18 Min: 4,15 Max: 4,77
Chiusura: 4,13

La tua Cronologia

NASDAQ
BCRX
BioCryst Pharmaceuticals
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network